HRP20171998T1 - Spojevi i sastavi za liječenje parazitnih bolesti - Google Patents
Spojevi i sastavi za liječenje parazitnih bolesti Download PDFInfo
- Publication number
- HRP20171998T1 HRP20171998T1 HRP20171998TT HRP20171998T HRP20171998T1 HR P20171998 T1 HRP20171998 T1 HR P20171998T1 HR P20171998T T HRP20171998T T HR P20171998TT HR P20171998 T HRP20171998 T HR P20171998T HR P20171998 T1 HRP20171998 T1 HR P20171998T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyridine
- pyrazolo
- carboxamide
- phenyl
- pyridin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 23
- 208000030852 Parasitic disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims 21
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 7
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- -1 amino, hydroxyl Chemical group 0.000 claims 5
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 101100097467 Arabidopsis thaliana SYD gene Proteins 0.000 claims 2
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 1
- HBDJXFWAWKERIG-UHFFFAOYSA-N 3-(2-aminopyridin-4-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=NC(N)=C1 HBDJXFWAWKERIG-UHFFFAOYSA-N 0.000 claims 1
- KCSUAVGGFJSNQG-UHFFFAOYSA-N 3-(2-aminopyrimidin-5-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)N=C1 KCSUAVGGFJSNQG-UHFFFAOYSA-N 0.000 claims 1
- GUKQBKQCUDJBSA-UHFFFAOYSA-N 3-(4-acetamidophenyl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(NC(C)=O)C=C1 GUKQBKQCUDJBSA-UHFFFAOYSA-N 0.000 claims 1
- PTEIXJMQQFZISE-UHFFFAOYSA-N 3-(4-amino-3,5-dimethylphenyl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC(C)=C(N)C(C)=C1 PTEIXJMQQFZISE-UHFFFAOYSA-N 0.000 claims 1
- ACEBZLKNNKVZGS-UHFFFAOYSA-N 3-(4-aminophenyl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(N)C=C1 ACEBZLKNNKVZGS-UHFFFAOYSA-N 0.000 claims 1
- BHSQRNJDDWAUDW-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-chloro-2-formylphenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=C(C=O)C=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 BHSQRNJDDWAUDW-UHFFFAOYSA-N 0.000 claims 1
- CEUMFLHANBUGHU-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-chlorophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 CEUMFLHANBUGHU-UHFFFAOYSA-N 0.000 claims 1
- GXWIIYKIVTXJHQ-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-cyanocyclohexyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(N)=O)=C2C=C1C(=O)N(C)C1CCC(C#N)CC1 GXWIIYKIVTXJHQ-UHFFFAOYSA-N 0.000 claims 1
- AVVFTCJUJWRJIF-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-cyanophenyl)-n-(2-hydroxyethyl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(CCO)C=3C=CC(=CC=3)C#N)C=CN2N=C1 AVVFTCJUJWRJIF-UHFFFAOYSA-N 0.000 claims 1
- RETWKVPBIKVKNP-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-cyanophenyl)-n-cyclopropylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 RETWKVPBIKVKNP-UHFFFAOYSA-N 0.000 claims 1
- RQRAIWVNBUQEFG-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 RQRAIWVNBUQEFG-UHFFFAOYSA-N 0.000 claims 1
- RYUOSSVZFZYALJ-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(4-fluorophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 RYUOSSVZFZYALJ-UHFFFAOYSA-N 0.000 claims 1
- PTWOKSFICCDWFV-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(5-cyanopyridin-2-yl)-n-(1-pyrazol-1-ylpropan-2-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(N)=O)=C2C=C1C(=O)N(C=1N=CC(=CC=1)C#N)C(C)CN1C=CC=N1 PTWOKSFICCDWFV-UHFFFAOYSA-N 0.000 claims 1
- ORBRBJUPZJBEFK-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(5-cyanopyridin-2-yl)-n-cyclopropylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 ORBRBJUPZJBEFK-UHFFFAOYSA-N 0.000 claims 1
- YTIYJNWWLQSAAU-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 YTIYJNWWLQSAAU-UHFFFAOYSA-N 0.000 claims 1
- JUNGICCWVXZLQG-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-cyclopropyl-n-(3,4-difluorophenyl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=C(F)C(F)=CC=3)C=CN2N=C1 JUNGICCWVXZLQG-UHFFFAOYSA-N 0.000 claims 1
- NYIRQOMRHCHWBH-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-methyl-n-(5-methylpyridin-2-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 NYIRQOMRHCHWBH-UHFFFAOYSA-N 0.000 claims 1
- NSCNEKGRISNFKI-UHFFFAOYSA-N 3-(4-carbamoylphenyl)-n-methyl-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C(F)(F)F)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 NSCNEKGRISNFKI-UHFFFAOYSA-N 0.000 claims 1
- HSRPYWABXCSKIO-UHFFFAOYSA-N 3-(4-fluorophenyl)-1-methyl-1-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]urea Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)NC1=CC=C(F)C=C1 HSRPYWABXCSKIO-UHFFFAOYSA-N 0.000 claims 1
- DUOVQOGMQOZJDE-UHFFFAOYSA-N 3-(5-amino-6-chloropyridin-3-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(Cl)C(N)=C1 DUOVQOGMQOZJDE-UHFFFAOYSA-N 0.000 claims 1
- HUHVFOSBOVRBBB-UHFFFAOYSA-N 3-(5-carbamoylpyridin-2-yl)-n-(4-cyanophenyl)-n-cyclopropylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 HUHVFOSBOVRBBB-UHFFFAOYSA-N 0.000 claims 1
- ZZXUGDGOKYDEDY-UHFFFAOYSA-N 3-(5-carbamoylpyridin-2-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=N1 ZZXUGDGOKYDEDY-UHFFFAOYSA-N 0.000 claims 1
- IBMMICVBFWIOGS-UHFFFAOYSA-N 3-(5-carbamoylpyridin-2-yl)-n-(5-cyanopyridin-2-yl)-n-cyclopropylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 IBMMICVBFWIOGS-UHFFFAOYSA-N 0.000 claims 1
- QTAMHHUFTFOTLR-UHFFFAOYSA-N 3-(5-carbamoylpyridin-2-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=N1 QTAMHHUFTFOTLR-UHFFFAOYSA-N 0.000 claims 1
- HAQDWUVBQZXLGW-UHFFFAOYSA-N 3-(6-acetamidopyridin-3-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(NC(C)=O)N=C1 HAQDWUVBQZXLGW-UHFFFAOYSA-N 0.000 claims 1
- LTAWNKYSHWNFMT-UHFFFAOYSA-N 3-(6-amino-5-chloropyridin-3-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)C(Cl)=C1 LTAWNKYSHWNFMT-UHFFFAOYSA-N 0.000 claims 1
- QOKZKONINLLRQF-UHFFFAOYSA-N 3-(6-amino-5-cyanopyridin-3-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)C(C#N)=C1 QOKZKONINLLRQF-UHFFFAOYSA-N 0.000 claims 1
- JYPKQLSJEKQADI-UHFFFAOYSA-N 3-(6-amino-5-fluoropyridin-3-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)C(F)=C1 JYPKQLSJEKQADI-UHFFFAOYSA-N 0.000 claims 1
- LCBMVGDIOXWCAR-UHFFFAOYSA-N 3-(6-amino-5-methoxypyridin-3-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=C(N)C(OC)=CC(C2=C3C=C(C=CN3N=C2)C(=O)N(C)C=2N=CC(=CC=2)C#N)=C1 LCBMVGDIOXWCAR-UHFFFAOYSA-N 0.000 claims 1
- MMVFCZWRKCJRRU-UHFFFAOYSA-N 3-(6-amino-5-methylpyridin-3-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)C(C)=C1 MMVFCZWRKCJRRU-UHFFFAOYSA-N 0.000 claims 1
- INEYQUSNXLVTDG-UHFFFAOYSA-N 3-(6-aminopyridin-3-yl)-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(N)N=C1 INEYQUSNXLVTDG-UHFFFAOYSA-N 0.000 claims 1
- VHVKCJJECWKSDS-UHFFFAOYSA-N 3-(6-aminopyridin-3-yl)-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(N)N=C1 VHVKCJJECWKSDS-UHFFFAOYSA-N 0.000 claims 1
- JJXDASHHKUGLBN-UHFFFAOYSA-N 3-(6-carbamoylpyridin-3-yl)-n-(4-cyanophenyl)-n-cyclopropylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 JJXDASHHKUGLBN-UHFFFAOYSA-N 0.000 claims 1
- XGMGXFIOFMLJIM-UHFFFAOYSA-N 3-[4-(2-aminoethylcarbamoyl)phenyl]-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NCCN)C=C1 XGMGXFIOFMLJIM-UHFFFAOYSA-N 0.000 claims 1
- NJXIVUGZDKCWEL-UHFFFAOYSA-N 3-[4-(methylcarbamoyl)phenyl]-n-propan-2-yl-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(=CC=3)C(F)(F)F)C=CN2N=C1 NJXIVUGZDKCWEL-UHFFFAOYSA-N 0.000 claims 1
- XCYDPRNLYOSTDK-UHFFFAOYSA-N 3-[4-[(2-aminoacetyl)amino]phenyl]-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(NC(=O)CN)C=C1 XCYDPRNLYOSTDK-UHFFFAOYSA-N 0.000 claims 1
- LYBINGBMBQCIEI-MRXNPFEDSA-N 3-[4-[[(2r)-2-aminopropanoyl]amino]phenyl]-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(NC(=O)[C@H](N)C)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 LYBINGBMBQCIEI-MRXNPFEDSA-N 0.000 claims 1
- IUMSUDBTXMWHOH-NDEPHWFRSA-N 3-[4-[[(2s)-2-amino-2-cyclohexylacetyl]amino]phenyl]-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1([C@H](N)C(=O)NC2=CC=C(C=C2)C=2C=NN3C=CC(=CC3=2)C(=O)N(C)C=2C=CC(=CC=2)C#N)CCCCC1 IUMSUDBTXMWHOH-NDEPHWFRSA-N 0.000 claims 1
- OJLDETSJNURQBL-VWLOTQADSA-N 3-[4-[[(2s)-2-amino-3-methylbutanoyl]amino]phenyl]-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(NC(=O)[C@@H](N)C(C)C)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 OJLDETSJNURQBL-VWLOTQADSA-N 0.000 claims 1
- LYBINGBMBQCIEI-INIZCTEOSA-N 3-[4-[[(2s)-2-aminopropanoyl]amino]phenyl]-n-(4-cyanophenyl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(NC(=O)[C@@H](N)C)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 LYBINGBMBQCIEI-INIZCTEOSA-N 0.000 claims 1
- XOEOHHSNJROFER-UHFFFAOYSA-N 3-[6-(methylcarbamoyl)pyridin-3-yl]-n-propan-2-yl-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(=CC=3)C(F)(F)F)C=CN2N=C1 XOEOHHSNJROFER-UHFFFAOYSA-N 0.000 claims 1
- INYLWQYLPVRIOG-UHFFFAOYSA-N 3-[6-amino-5-(dimethylcarbamoyl)pyridin-3-yl]-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=C(N)C(C(=O)N(C)C)=CC(C2=C3C=C(C=CN3N=C2)C(=O)N(C)C=2N=CC(=CC=2)C#N)=C1 INYLWQYLPVRIOG-UHFFFAOYSA-N 0.000 claims 1
- LQQLJLYZAUDRTO-UHFFFAOYSA-N 3-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(N)C(C(F)(F)F)=C1 LQQLJLYZAUDRTO-UHFFFAOYSA-N 0.000 claims 1
- WMTRRHDMJAGPOE-UHFFFAOYSA-N 3-[6-chloro-5-(methanesulfonamido)pyridin-3-yl]-n-(5-cyanopyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CN=C(Cl)C(NS(C)(=O)=O)=C1 WMTRRHDMJAGPOE-UHFFFAOYSA-N 0.000 claims 1
- XFLNXYYZBCWZOZ-UHFFFAOYSA-N 4-[5-(7-fluoro-2,3-dihydro-1,4-benzoxazine-4-carbonyl)pyrazolo[1,5-a]pyridin-3-yl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N3C4=CC=C(F)C=C4OCC3)C=CN2N=C1 XFLNXYYZBCWZOZ-UHFFFAOYSA-N 0.000 claims 1
- YWGFPJBLWOENPW-UHFFFAOYSA-N 4-[5-(7-fluoro-2,3-dihydro-1,4-benzoxazine-4-carbonyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(C(=O)N3C4=CC=C(F)C=C4OCC3)C=CN2N=C1 YWGFPJBLWOENPW-UHFFFAOYSA-N 0.000 claims 1
- JQKWXWZESAYCIW-UHFFFAOYSA-N 4-[5-(7-fluoro-3-methyl-2,3-dihydro-1,4-benzoxazine-4-carbonyl)pyrazolo[1,5-a]pyridin-3-yl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N3C4=CC=C(F)C=C4OCC3C)C=CN2N=C1 JQKWXWZESAYCIW-UHFFFAOYSA-N 0.000 claims 1
- ZEKPCJGRTFGZLB-UHFFFAOYSA-N 4-[5-(7-fluoro-3-methyl-2,3-dihydro-1,4-benzoxazine-4-carbonyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound CC1COC2=CC(F)=CC=C2N1C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 ZEKPCJGRTFGZLB-UHFFFAOYSA-N 0.000 claims 1
- VIWNXLMAPVRFHB-UHFFFAOYSA-N 4-[5-[(4-fluorobenzoyl)-methylamino]pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(N)=O)=C2C=C1N(C)C(=O)C1=CC=C(F)C=C1 VIWNXLMAPVRFHB-UHFFFAOYSA-N 0.000 claims 1
- DLGFTAJFANEHOI-UHFFFAOYSA-N 4-[5-[(5-cyanopyridin-2-yl)-cyclopropylsulfamoyl]pyrazolo[1,5-a]pyridin-3-yl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(S(=O)(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 DLGFTAJFANEHOI-UHFFFAOYSA-N 0.000 claims 1
- MQQLWULRXYGMPH-UHFFFAOYSA-N 4-[5-[(5-cyanopyridin-2-yl)-cyclopropylsulfamoyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=C2C=C(S(=O)(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 MQQLWULRXYGMPH-UHFFFAOYSA-N 0.000 claims 1
- WTEJFLHRTLMMED-UHFFFAOYSA-N 4-[5-[(5-cyanopyridin-2-yl)-methylcarbamoyl]pyrazolo[1,5-a]pyridin-3-yl]benzoic acid Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(O)=O)C=C1 WTEJFLHRTLMMED-UHFFFAOYSA-N 0.000 claims 1
- SQOAOCLLZSNKEJ-UHFFFAOYSA-N 4-[5-[1-(7-fluoro-3-oxo-1,4-benzoxazin-4-yl)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound O=C1COC2=CC(F)=CC=C2N1C(C)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(N)=O)C=C1 SQOAOCLLZSNKEJ-UHFFFAOYSA-N 0.000 claims 1
- OXMVLJHPBWICNO-UHFFFAOYSA-N 4-[5-[1-[methyl-(5-methylpyridin-2-yl)amino]ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(N)=O)=C2C=C1C(C)N(C)C1=CC=C(C)C=N1 OXMVLJHPBWICNO-UHFFFAOYSA-N 0.000 claims 1
- FOMOTRJNAJNRTM-UHFFFAOYSA-N 4-chloro-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(Cl)C=C1 FOMOTRJNAJNRTM-UHFFFAOYSA-N 0.000 claims 1
- MKWHZSORVFXAAC-UHFFFAOYSA-N 4-chloro-n-methyl-n-[[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]methyl]aniline Chemical compound C=1C=C(Cl)C=CC=1N(C)CC(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 MKWHZSORVFXAAC-UHFFFAOYSA-N 0.000 claims 1
- TXSNDSCJHXCDRG-UHFFFAOYSA-N 4-cyano-n-(oxan-4-ylmethyl)-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=C2C=C(N(CC3CCOCC3)C(=O)C=3C=CC(=CC=3)C#N)C=CN2N=C1 TXSNDSCJHXCDRG-UHFFFAOYSA-N 0.000 claims 1
- MKXLMCMKNQXGAS-UHFFFAOYSA-N 4-cyano-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(C#N)C=C1 MKXLMCMKNQXGAS-UHFFFAOYSA-N 0.000 claims 1
- LFMDYWOTIXBDRY-UHFFFAOYSA-N 4-cyano-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzenesulfonamide Chemical compound C=1C=C(C#N)C=CC=1S(=O)(=O)N(C)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 LFMDYWOTIXBDRY-UHFFFAOYSA-N 0.000 claims 1
- OBTXCMGPGHMGIT-UHFFFAOYSA-N 4-cyclopropyl-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C(C=C1)=CC=C1C1CC1 OBTXCMGPGHMGIT-UHFFFAOYSA-N 0.000 claims 1
- ZIVQLWKYVSHZJA-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(F)C=C1 ZIVQLWKYVSHZJA-UHFFFAOYSA-N 0.000 claims 1
- CXJIVALQEWZFDB-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzenesulfonamide Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)N(C)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 CXJIVALQEWZFDB-UHFFFAOYSA-N 0.000 claims 1
- YLUAYXLDRUPROY-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[3-[4-[5-(methylamino)-1,3,4-thiadiazol-2-yl]phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound S1C(NC)=NN=C1C1=CC=C(C2=C3C=C(C=CN3N=C2)N(C)C(=O)C=2C=CC(F)=CC=2)C=C1 YLUAYXLDRUPROY-UHFFFAOYSA-N 0.000 claims 1
- YKEOOCRGJWUBBL-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]methyl]aniline Chemical compound C=1C=C(F)C=CC=1N(C)CC(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 YKEOOCRGJWUBBL-UHFFFAOYSA-N 0.000 claims 1
- POPQAGDJJFNTNA-UHFFFAOYSA-N 5-[(4-fluorophenoxy)methyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1OCC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 POPQAGDJJFNTNA-UHFFFAOYSA-N 0.000 claims 1
- MNCSCAZLWXELFK-UHFFFAOYSA-N 5-[(4-fluorophenyl)sulfanylmethyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1SCC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 MNCSCAZLWXELFK-UHFFFAOYSA-N 0.000 claims 1
- MCROLCIKKFTXML-UHFFFAOYSA-N 5-[(4-fluorophenyl)sulfinylmethyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1S(=O)CC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 MCROLCIKKFTXML-UHFFFAOYSA-N 0.000 claims 1
- HAAMTDVCPQYNMK-UHFFFAOYSA-N 5-[(5-methylpyridin-2-yl)oxymethyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine Chemical compound N1=CC(C)=CC=C1OCC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 HAAMTDVCPQYNMK-UHFFFAOYSA-N 0.000 claims 1
- GOEFACQHAYWRAQ-UHFFFAOYSA-N 5-[2-(4-fluorophenyl)ethyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine Chemical compound C1=CC(F)=CC=C1CCC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 GOEFACQHAYWRAQ-UHFFFAOYSA-N 0.000 claims 1
- VQPZEJHSUIMXJJ-UHFFFAOYSA-N 5-[5-[(4-cyanophenyl)-(methylamino)carbamoyl]pyrazolo[1,5-a]pyridin-3-yl]-n-methylpyridine-2-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(NC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)N=C1 VQPZEJHSUIMXJJ-UHFFFAOYSA-N 0.000 claims 1
- BYVIYMRAMUIJPT-UHFFFAOYSA-N 5-cyano-n-methyl-n-[3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(N(C)C(=O)C=3N=CC(=CC=3)C#N)C=CN2N=C1 BYVIYMRAMUIJPT-UHFFFAOYSA-N 0.000 claims 1
- YWKYEPUNTVWLHL-UHFFFAOYSA-N 5-fluoro-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-2-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(F)C=N1 YWKYEPUNTVWLHL-UHFFFAOYSA-N 0.000 claims 1
- UIELNVXYHJIHQY-UHFFFAOYSA-N 6-(1,1-difluoroethyl)-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-3-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(C(C)(F)F)N=C1 UIELNVXYHJIHQY-UHFFFAOYSA-N 0.000 claims 1
- VYLUHYBMTOAFRM-UHFFFAOYSA-N 6-[cyclopropyl-[3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl]amino]pyridine-3-carboxylic acid Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C(O)=O)C=CN2N=C1 VYLUHYBMTOAFRM-UHFFFAOYSA-N 0.000 claims 1
- WDEOEMVXDSLHMP-UHFFFAOYSA-N 6-cyclopropyl-n-methyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-3-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C(C=N1)=CC=C1C1CC1 WDEOEMVXDSLHMP-UHFFFAOYSA-N 0.000 claims 1
- YCGQUZBFFSNOKK-UHFFFAOYSA-N N-(4-cyanophenyl)-N-cyclopropyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound CNC(=O)c1ccc(cn1)-c1cnn2ccc(cc12)C(=O)N(C1CC1)c1ccc(cc1)C#N YCGQUZBFFSNOKK-UHFFFAOYSA-N 0.000 claims 1
- 241000223960 Plasmodium falciparum Species 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000008029 eradication Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000006872 improvement Effects 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 201000004792 malaria Diseases 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- IALWQEFKCYAWAN-UHFFFAOYSA-N n,5-dimethyl-n-[[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]methyl]pyridin-2-amine Chemical compound C=1C=C(C)C=NC=1N(C)CC(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 IALWQEFKCYAWAN-UHFFFAOYSA-N 0.000 claims 1
- QLBMKYCSDKNZAL-UHFFFAOYSA-N n-(4-chlorophenyl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(Cl)=CC=3)C=CN2N=C1 QLBMKYCSDKNZAL-UHFFFAOYSA-N 0.000 claims 1
- YCWKWWREAWIMNT-UHFFFAOYSA-N n-(4-chlorophenyl)-n-cyclopropyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(Cl)=CC=3)C=CN2N=C1 YCWKWWREAWIMNT-UHFFFAOYSA-N 0.000 claims 1
- RQUPCQCXFLJNEN-UHFFFAOYSA-N n-(4-chlorophenyl)-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(Cl)=CC=3)C=CN2N=C1 RQUPCQCXFLJNEN-UHFFFAOYSA-N 0.000 claims 1
- RUSOLNJHZUEOGG-UHFFFAOYSA-N n-(4-chlorophenyl)-n-methyl-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 RUSOLNJHZUEOGG-UHFFFAOYSA-N 0.000 claims 1
- RPJPDDLMNXIQOV-UHFFFAOYSA-N n-(4-chlorophenyl)-n-methyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(Cl)=CC=3)C=CN2N=C1 RPJPDDLMNXIQOV-UHFFFAOYSA-N 0.000 claims 1
- RQSSKSHYMKUEAE-UHFFFAOYSA-N n-(4-cyanophenyl)-3-[6-(methylcarbamoyl)pyridin-3-yl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 RQSSKSHYMKUEAE-UHFFFAOYSA-N 0.000 claims 1
- IVSTYLJEZTVXAI-UHFFFAOYSA-N n-(4-cyanophenyl)-n-(2-hydroxyethyl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(CCO)C=3C=CC(=CC=3)C#N)C=CN2N=C1 IVSTYLJEZTVXAI-UHFFFAOYSA-N 0.000 claims 1
- MVQRJMLNKDHGIF-UHFFFAOYSA-N n-(4-cyanophenyl)-n-(2-methoxyethyl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(CCOC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 MVQRJMLNKDHGIF-UHFFFAOYSA-N 0.000 claims 1
- UGEZWGJFGVLGJV-UHFFFAOYSA-N n-(4-cyanophenyl)-n-(oxan-4-ylmethyl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=C2C=C(C(=O)N(CC3CCOCC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 UGEZWGJFGVLGJV-UHFFFAOYSA-N 0.000 claims 1
- QHQWPRDOKMQBPX-UHFFFAOYSA-N n-(4-cyanophenyl)-n-[2-(dimethylamino)ethyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(CCN(C)C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 QHQWPRDOKMQBPX-UHFFFAOYSA-N 0.000 claims 1
- RXTIWOYOWHYIAG-UHFFFAOYSA-N n-(4-cyanophenyl)-n-cyclobutyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 RXTIWOYOWHYIAG-UHFFFAOYSA-N 0.000 claims 1
- JIIUPZKZQNHKJP-UHFFFAOYSA-N n-(4-cyanophenyl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 JIIUPZKZQNHKJP-UHFFFAOYSA-N 0.000 claims 1
- DUMSENAXSREFPY-UHFFFAOYSA-N n-(4-cyanophenyl)-n-cyclopropyl-3-[5-(methylcarbamoyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=CC(=CC=3)C#N)C=CN2N=C1 DUMSENAXSREFPY-UHFFFAOYSA-N 0.000 claims 1
- YRWKBQVVZAEPST-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-(1-methylindazol-5-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=C4C=NN(C)C4=CC=3)=C2C=C1C(=O)N(C)C1=CC=C(C#N)C=C1 YRWKBQVVZAEPST-UHFFFAOYSA-N 0.000 claims 1
- DQHCWIQEOFOVPG-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=C4C=CNC4=NC=3)=C2C=C1C(=O)N(C)C1=CC=C(C#N)C=C1 DQHCWIQEOFOVPG-UHFFFAOYSA-N 0.000 claims 1
- BZAYVUAXBIQRQQ-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-[4-(1h-pyrazol-5-yl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C(C=C1)=CC=C1C1=CC=NN1 BZAYVUAXBIQRQQ-UHFFFAOYSA-N 0.000 claims 1
- NARYPCJDJASVKH-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 NARYPCJDJASVKH-UHFFFAOYSA-N 0.000 claims 1
- FUAXSFPIDJXYEF-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 FUAXSFPIDJXYEF-UHFFFAOYSA-N 0.000 claims 1
- HSYFIBRVTQDCQH-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=N1 HSYFIBRVTQDCQH-UHFFFAOYSA-N 0.000 claims 1
- FFXJDPAXCZHDGF-UHFFFAOYSA-N n-(4-cyanophenyl)-n-methyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C#N)C=CN2N=C1 FFXJDPAXCZHDGF-UHFFFAOYSA-N 0.000 claims 1
- KCGZYEZWFCJEHO-UHFFFAOYSA-N n-(4-fluorophenyl)-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(F)=CC=3)C=CN2N=C1 KCGZYEZWFCJEHO-UHFFFAOYSA-N 0.000 claims 1
- KUUWPDFSONAWGQ-UHFFFAOYSA-N n-(4-fluorophenyl)-n-methyl-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 KUUWPDFSONAWGQ-UHFFFAOYSA-N 0.000 claims 1
- FALJOYOYFPBVSB-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-n-(oxan-4-ylmethyl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N(C(=O)C1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1)CC1CCOCC1 FALJOYOYFPBVSB-UHFFFAOYSA-N 0.000 claims 1
- OSWSESLZUZQSOP-UHFFFAOYSA-N n-(5-carbamoylpyridin-2-yl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C(N)=O)C=CN2N=C1 OSWSESLZUZQSOP-UHFFFAOYSA-N 0.000 claims 1
- PNWVUEJZKSPMJI-UHFFFAOYSA-N n-(5-chloropyridin-2-yl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(Cl)=CC=3)C=CN2N=C1 PNWVUEJZKSPMJI-UHFFFAOYSA-N 0.000 claims 1
- RRGXKLWHKMFJGY-UHFFFAOYSA-N n-(5-cyano-6-methoxypyridin-2-yl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=C(OC)C(C#N)=CC=3)C=CN2N=C1 RRGXKLWHKMFJGY-UHFFFAOYSA-N 0.000 claims 1
- IYEKAGXIGWYWCV-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-(5-methoxypyridin-2-yl)-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(OC)=CC=C1C1=C2C=C(C(=O)N(C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 IYEKAGXIGWYWCV-UHFFFAOYSA-N 0.000 claims 1
- DCWOLPHZFUNUCT-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[4-(2-hydroxyethylcarbamoyl)phenyl]-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NCCO)C=C1 DCWOLPHZFUNUCT-UHFFFAOYSA-N 0.000 claims 1
- CZQAJWCLHUCGTB-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]-n-(oxetan-3-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3COC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 CZQAJWCLHUCGTB-UHFFFAOYSA-N 0.000 claims 1
- OVGPNIIHANOLRC-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 OVGPNIIHANOLRC-UHFFFAOYSA-N 0.000 claims 1
- GGDDEXIVBFQSAN-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)NC=3N=CC(=CC=3)C#N)C=CN2N=C1 GGDDEXIVBFQSAN-UHFFFAOYSA-N 0.000 claims 1
- YSFOYPLRLSUXGD-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[4-[2-(dimethylamino)ethylcarbamoyl]phenyl]-n-methylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NCCN(C)C)=CC=C1C1=C2C=C(C(=O)N(C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 YSFOYPLRLSUXGD-UHFFFAOYSA-N 0.000 claims 1
- ZUHAYTHYUNRADF-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[5-(methylcarbamoyl)pyridin-2-yl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 ZUHAYTHYUNRADF-UHFFFAOYSA-N 0.000 claims 1
- DAPDGWYVUVKKAW-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-3-[6-(methylcarbamoyl)pyridin-3-yl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 DAPDGWYVUVKKAW-UHFFFAOYSA-N 0.000 claims 1
- UXEFDFKYPJBLAT-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-(cyclopropylmethyl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(CC3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 UXEFDFKYPJBLAT-UHFFFAOYSA-N 0.000 claims 1
- KPXLMZFJOWIJLL-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclobutyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 KPXLMZFJOWIJLL-UHFFFAOYSA-N 0.000 claims 1
- MQLKMEHORCNIQH-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclobutyl-3-[5-(methylcarbamoyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 MQLKMEHORCNIQH-UHFFFAOYSA-N 0.000 claims 1
- MTOFAYNZWROOFL-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclobutyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 MTOFAYNZWROOFL-UHFFFAOYSA-N 0.000 claims 1
- KPMLXSCRXLUDRE-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopentyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCCC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 KPMLXSCRXLUDRE-UHFFFAOYSA-N 0.000 claims 1
- OWJZSPIQRDWDOQ-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[4-(cyclopropylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C2=C3C=C(C=CN3N=C2)C(=O)N(C2CC2)C=2N=CC(=CC=2)C#N)C=CC=1C(=O)NC1CC1 OWJZSPIQRDWDOQ-UHFFFAOYSA-N 0.000 claims 1
- SHBGMUKYDCLJBK-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[4-(ethylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NCC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 SHBGMUKYDCLJBK-UHFFFAOYSA-N 0.000 claims 1
- MIVQLYOYCUPNAP-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 MIVQLYOYCUPNAP-UHFFFAOYSA-N 0.000 claims 1
- WYJFZJKZCSUHBX-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[4-(oxetan-3-ylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C2=C3C=C(C=CN3N=C2)C(=O)N(C2CC2)C=2N=CC(=CC=2)C#N)C=CC=1C(=O)NC1COC1 WYJFZJKZCSUHBX-UHFFFAOYSA-N 0.000 claims 1
- YWRPRHSTTAXOEV-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[4-(propan-2-ylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC(C)C)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 YWRPRHSTTAXOEV-UHFFFAOYSA-N 0.000 claims 1
- KFOMSSFVJIRHPU-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-cyclopropyl-3-[5-(methylcarbamoyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C#N)C=CN2N=C1 KFOMSSFVJIRHPU-UHFFFAOYSA-N 0.000 claims 1
- JNJAHAZYYYDJAP-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-ethyl-3-(4-methylsulfonylphenyl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(S(C)(=O)=O)C=C1 JNJAHAZYYYDJAP-UHFFFAOYSA-N 0.000 claims 1
- XOHVCFFOEUGXDR-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-ethyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)C=C1 XOHVCFFOEUGXDR-UHFFFAOYSA-N 0.000 claims 1
- LEWMNNNBKDRYRQ-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-ethyl-3-[4-(methylsulfamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(S(=O)(=O)NC)C=C1 LEWMNNNBKDRYRQ-UHFFFAOYSA-N 0.000 claims 1
- UFYBPEINJLXMDB-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-ethyl-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)N=C1 UFYBPEINJLXMDB-UHFFFAOYSA-N 0.000 claims 1
- IHZSERRLWDIUDF-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=C4C=CNC4=NC=3)=C2C=C1C(=O)N(C)C1=CC=C(C#N)C=N1 IHZSERRLWDIUDF-UHFFFAOYSA-N 0.000 claims 1
- FBDMSZQQZWJIPM-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-(5-methylpyridin-2-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C)C=N1 FBDMSZQQZWJIPM-UHFFFAOYSA-N 0.000 claims 1
- AFEBSUBJPYNMLX-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 AFEBSUBJPYNMLX-UHFFFAOYSA-N 0.000 claims 1
- RTWXRNVTDKFFAB-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-[4-(piperidin-4-ylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C(C=C1)=CC=C1C(=O)NC1CCNCC1 RTWXRNVTDKFFAB-UHFFFAOYSA-N 0.000 claims 1
- NYKBGHFUPNQBFS-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 NYKBGHFUPNQBFS-UHFFFAOYSA-N 0.000 claims 1
- IFDCMIQEJLDPHE-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-[4-[2-(methylamino)ethylcarbamoyl]phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NCCNC)=CC=C1C1=C2C=C(C(=O)N(C)C=3N=CC(=CC=3)C#N)C=CN2N=C1 IFDCMIQEJLDPHE-UHFFFAOYSA-N 0.000 claims 1
- CASVUIQEVGEGCP-UHFFFAOYSA-N n-(5-cyanopyridin-2-yl)-n-methyl-3-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=N1 CASVUIQEVGEGCP-UHFFFAOYSA-N 0.000 claims 1
- RRAJGXZXMPVYSL-UHFFFAOYSA-N n-(5-fluoropyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(F)=CC=3)C=CN2N=C1 RRAJGXZXMPVYSL-UHFFFAOYSA-N 0.000 claims 1
- HTICUJAUGNQCOU-UHFFFAOYSA-N n-(5-fluoropyridin-2-yl)-3-[6-(methylcarbamoyl)pyridin-3-yl]-n-propan-2-ylpyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C(C)C)C=3N=CC(F)=CC=3)C=CN2N=C1 HTICUJAUGNQCOU-UHFFFAOYSA-N 0.000 claims 1
- VHCNDWGSINHRFQ-UHFFFAOYSA-N n-(6-methoxypyridin-3-yl)-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=NC(OC)=CC=3)C=CN2N=C1 VHCNDWGSINHRFQ-UHFFFAOYSA-N 0.000 claims 1
- NAUKWDRTUSNMMD-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-amine Chemical compound C1=CC(F)=CC=C1CNC1=CC2=C(C=3C=CC(=CC=3)C(F)(F)F)C=NN2C=C1 NAUKWDRTUSNMMD-UHFFFAOYSA-N 0.000 claims 1
- ZDBCNJLQLIHTFV-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-n-methyl-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-amine Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)CC1=CC=C(F)C=C1 ZDBCNJLQLIHTFV-UHFFFAOYSA-N 0.000 claims 1
- YPTLWTAKBWMQEP-UHFFFAOYSA-N n-[4-[5-[1-[methyl-(5-methylpyridin-2-yl)amino]ethyl]pyrazolo[1,5-a]pyridin-3-yl]phenyl]acetamide Chemical compound C1=CN2N=CC(C=3C=CC(NC(C)=O)=CC=3)=C2C=C1C(C)N(C)C1=CC=C(C)C=N1 YPTLWTAKBWMQEP-UHFFFAOYSA-N 0.000 claims 1
- MNWWEGIFDNKMNJ-UHFFFAOYSA-N n-[5-(2-aminoethoxy)pyridin-2-yl]-n-methyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3N=CC(OCCN)=CC=3)C=CN2N=C1 MNWWEGIFDNKMNJ-UHFFFAOYSA-N 0.000 claims 1
- ANYOQUOLOWBNEU-UHFFFAOYSA-N n-[5-cyano-6-(2-hydroxyethoxy)pyridin-2-yl]-n-ethyl-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C#N)C(OCCO)=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)C=C1 ANYOQUOLOWBNEU-UHFFFAOYSA-N 0.000 claims 1
- ZHYBQKPEVSYJBI-UHFFFAOYSA-N n-cyclobutyl-3-[4-(methylcarbamoyl)phenyl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3N=CC(=CC=3)C(F)(F)F)C=CN2N=C1 ZHYBQKPEVSYJBI-UHFFFAOYSA-N 0.000 claims 1
- VYYAOGPGWYRDSF-UHFFFAOYSA-N n-cyclobutyl-3-[6-(methylcarbamoyl)pyridin-3-yl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CCC3)C=3N=CC(=CC=3)C(F)(F)F)C=CN2N=C1 VYYAOGPGWYRDSF-UHFFFAOYSA-N 0.000 claims 1
- FWPHMGNLBGSHOU-UHFFFAOYSA-N n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]-n-(5-methylpyridin-2-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(C)=CC=3)C=CN2N=C1 FWPHMGNLBGSHOU-UHFFFAOYSA-N 0.000 claims 1
- YIUYQVZGKNXGTF-UHFFFAOYSA-N n-cyclopropyl-3-[4-(methylcarbamoyl)phenyl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(=CC=3)C(F)(F)F)C=CN2N=C1 YIUYQVZGKNXGTF-UHFFFAOYSA-N 0.000 claims 1
- OJKLFHNVCKXTSV-UHFFFAOYSA-N n-cyclopropyl-n-(3,4-difluorophenyl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3C=C(F)C(F)=CC=3)C=CN2N=C1 OJKLFHNVCKXTSV-UHFFFAOYSA-N 0.000 claims 1
- AIJSPOWXEMAGDY-UHFFFAOYSA-N n-cyclopropyl-n-(5-fluoropyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C3CC3)C=3N=CC(F)=CC=3)C=CN2N=C1 AIJSPOWXEMAGDY-UHFFFAOYSA-N 0.000 claims 1
- FIMDPLQFEMZNQZ-UHFFFAOYSA-N n-ethyl-3-[4-(methylcarbamoyl)phenyl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C(F)(F)F)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)C=C1 FIMDPLQFEMZNQZ-UHFFFAOYSA-N 0.000 claims 1
- YAXCNOBBZZXYBG-UHFFFAOYSA-N n-ethyl-3-[6-(methylcarbamoyl)pyridin-3-yl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C(F)(F)F)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)N=C1 YAXCNOBBZZXYBG-UHFFFAOYSA-N 0.000 claims 1
- YVQPAOQGADXRII-UHFFFAOYSA-N n-ethyl-n-(5-fluoropyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)C=C1 YVQPAOQGADXRII-UHFFFAOYSA-N 0.000 claims 1
- KGZDTZLJJQQLOM-UHFFFAOYSA-N n-ethyl-n-(5-fluoropyridin-2-yl)-3-[6-(methylcarbamoyl)pyridin-3-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=NC=1N(CC)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(=O)NC)N=C1 KGZDTZLJJQQLOM-UHFFFAOYSA-N 0.000 claims 1
- ZTGKBOUPFXOCCR-UHFFFAOYSA-N n-methyl-3-[4-(methylcarbamoyl)phenyl]-n-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C)C=3C=CC(=CC=3)C(F)(F)F)C=CN2N=C1 ZTGKBOUPFXOCCR-UHFFFAOYSA-N 0.000 claims 1
- INCKNTIYZVAHFT-UHFFFAOYSA-N n-methyl-3-[4-(trifluoromethyl)phenyl]-n-[5-(trifluoromethyl)pyridin-2-yl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C(F)(F)F)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 INCKNTIYZVAHFT-UHFFFAOYSA-N 0.000 claims 1
- OGRSJOKFJKMBLF-UHFFFAOYSA-N n-methyl-4-methylsulfonyl-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]benzamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(S(C)(=O)=O)C=C1 OGRSJOKFJKMBLF-UHFFFAOYSA-N 0.000 claims 1
- CCSAXDPRAJEOCX-UHFFFAOYSA-N n-methyl-5-(trifluoromethyl)-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-2-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(C(F)(F)F)C=N1 CCSAXDPRAJEOCX-UHFFFAOYSA-N 0.000 claims 1
- CQTFNXGRFYJAJX-UHFFFAOYSA-N n-methyl-6-(trifluoromethyl)-n-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-5-yl]pyridine-3-carboxamide Chemical compound C1=CN2N=CC(C=3C=CC(=CC=3)C(F)(F)F)=C2C=C1N(C)C(=O)C1=CC=C(C(F)(F)F)N=C1 CQTFNXGRFYJAJX-UHFFFAOYSA-N 0.000 claims 1
- DMIUBBRIWCMDNC-UHFFFAOYSA-N n-methyl-n-(5-methylpyridin-2-yl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 DMIUBBRIWCMDNC-UHFFFAOYSA-N 0.000 claims 1
- RKHNDRNBMJFYCQ-UHFFFAOYSA-N n-methyl-n-(5-methylpyridin-3-yl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1N=CC(C)=CC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 RKHNDRNBMJFYCQ-UHFFFAOYSA-N 0.000 claims 1
- IIHBEQNZSUCAIJ-UHFFFAOYSA-N n-methyl-n-(5-methylsulfonylpyridin-2-yl)-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CN2N=CC(C=3C=C4C=CNC4=NC=3)=C2C=C1C(=O)N(C)C1=CC=C(S(C)(=O)=O)C=N1 IIHBEQNZSUCAIJ-UHFFFAOYSA-N 0.000 claims 1
- HTYGVHVYHKRGNC-UHFFFAOYSA-N n-methyl-n-(5-methylsulfonylpyridin-2-yl)-3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C=1C=C(S(C)(=O)=O)C=NC=1N(C)C(=O)C(=CC1=2)C=CN1N=CC=2C1=CC=C(C(F)(F)F)C=C1 HTYGVHVYHKRGNC-UHFFFAOYSA-N 0.000 claims 1
- CTFVSGFULJBVIW-UHFFFAOYSA-N n-tert-butyl-n-(5-cyanopyridin-2-yl)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=C2C=C(C(=O)N(C=3N=CC(=CC=3)C#N)C(C)(C)C)C=CN2N=C1 CTFVSGFULJBVIW-UHFFFAOYSA-N 0.000 claims 1
- 125000003566 oxetanyl group Chemical group 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- DVUBDHRTVYLIPA-UHFFFAOYSA-N pyrazolo[1,5-a]pyridine Chemical group C1=CC=CN2N=CC=C21 DVUBDHRTVYLIPA-UHFFFAOYSA-N 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Claims (21)
1. Spoj, naznačen time, da ima sljedeću Formulu I:
[image]
ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, gdje
n je 0, 1, 2 ili 3;
p je 0, 1, 2 ili 3;
L je odabran iz skupine koju čine: *-(CHR3)1-3-, *-CHR3N(R2)-, *-CHR3O-, *-CHR3S-, *-CHR3S(O)-, *-CHR3N(R2)CHR3-, * C(O)-, *-C(O)N(R2)-, *-C(O)N(R2)CHR3-, *-N(R2)-, *-N(R2)CHR3-, *-N(R2)C(O)-, *-N(R2)C(O)N(R2)-, *-N(R2)S(O)2-, pri čemu
* predstavlja točku priključenja od L na staljeni pirazolo[1,5-a]piridin-prsten izražen u Formuli I;
svaki R2 je neovisno odabran iz skupine koju čine: vodik, C1-6alkil, haloC1-6alkil, R-C0-4alkilen, i R-C0-4 alkilen-C(O)-, dok je R odabran iz skupine koju čine: hidroksil, C1-4alkoksi, amino, C1-4alkilamino, C3-6 cikloalkil, C4-6heterocikloalkil, i C5-6heteroaril, gdje je svaki od C3-6cikloalkila, C4-6heterocikloalkila i C5-6 heteroarila od R, nesupstituiran ili supstituiran s 1-2 supstituenta neovisno odabrana iz skupine koju čine: halo, amino, hidroksil, C1-4alkil, C1-4alkoksi, okso, i C5-6heteroaril; i svaki R3 je neovisno odabran iz skupine koju čine: vodik i C1-4alkil;
Prsten A je odabran iz skupine koju čine: C6-10aril i C5-10heteroaril;
Prsten C je odabran iz skupine koju čine: C6-10aril, C5-10heteroaril, C5-7cikloalkil, C5-7heterocikloalkil, i staljeni biciklil koji obuhvaća C5-6heterocikloalkil staljen na fenil;
svaki R1 je neovisno odabran iz skupine koju čine: halo, cijano, amino, C1-4alkil, C1-4alkoksil, halo-C1-4alkil, -C(O)NR7R8, -NHC(O)R11, fenil, i C5-6heteroaril;
pri čemu je svaki od fenila i C5-6heteroarila od R1, nesupstituiran ili supstituiran s 1-2 supstituenta neovisno odabrana iz skupine koju čine: C1-4alkil, amino, halo, i C1-4alkilamino;
svaki od R7 i R8 je neovisno odabran od vodika, C1-4alkila i haloC1-4alkila;
R11 je C1-6alkil, nesupstituiran ili supstituiran s 1-2 supstituenta neovisno odabrana iz skupine koju čine sljedeći: amino, C3-6cikloalkil i C4-6heterocikloalkil;
R17 je odabran iz skupine koju čine sljedeći: cijano, halo, C1-4alkil, halo-C1-4alkil, okso, C3-6cikloalkil, i -SO2-C1-4alkil.
2. Spoj prema zahtjevu 1, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je L odabran iz skupine koja se sastoji od *-C(O)N(R2)-, i *-N(R2)C(O)-, dok je svaki R2 neovisno odabran od sljedećih: vodik, C1-4alkil, i R-C0-4alkilen, i gdje je R odabran iz skupine koja se sastoji od sljedećih: C1-4 alkilamino, C3-6cikloalkil, C4-6heterocikloalkil i C5-6heteroaril, pri čemu je svaki od C3-6cikloalkila, C4-6 heterocikloalkila i C5-6heteroarila, nesupstituiran ili supstituiran s 1-2 supstituenta neovisno odabrana iz skupine koju čine: halo, amino, hidroksil, C1-4alkil, C1-4alkoksi, okso, i C5-6heteroaril.
3. Spoj prema zahtjevu 1, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je L odabran od sljedećih:
*-C(O)N(CH3)-, *-C(O)N(CH2CH3)-, *-C(O)N(CH(CH3)2)-, *-C(O)N(NH(CH3))-, i *-N(CH3)C(O)-.
4. Spoj prema bilo kojem od zahtjeva 1 do 3, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je Prsten A odabran iz skupine koja se sastoji od sljedećih: fenil, piridinil, pirimidinil, pirazinil, piridazinil, pirolopiridinil i indazolil, od kojih je svaki nesupstituiran ili supstituiran s (R1)n.
5. Spoj prema bilo kojem od zahtjeva 1 do 4, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je Prsten C odabran iz skupine koja se sastoji od sljedećih:
[image]
od kojih je svaki nesupstituiran ili supstituiran s (R17)p.
6. Spoj prema bilo kojem od zahtjeva 1 do 4, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je Prsten C odabran iz skupine koja se sastoji od fenila i piridinila, od kojih je svaki nesupstituiran ili supstituiran s (R17)p.
7. Spoj prema bilo kojem od zahtjeva 1 do 6, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je svaki R1 neovisno odabran iz skupine koja se sastoji od sljedećih: trifluorometil, cijano, -NH2, -C(O)NH2, -C(O)NHCH3, C(O)N(CH3)2, i -NHC(O)CH(NH2)(CH3).
8. Spoj prema bilo kojem od zahtjeva 1 do 7, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da je svaki R17 neovisno odabran iz skupine koja se sastoji od sljedećih: cijano, halo, C1-4alkil, haloC1-4alkil, -SO2-C1-4alkil, i C3-6cikloalkil.
9. Spoj, naznačen time, da ima sljedeću Formulu Ia:
[image]
ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer,
u kojoj
n je 1 ili 2;
Prsten A je fenil, piridinil ili pirimidinil;
Prsten C je fenil ili piridinil;
L je *-C(O)NR2 ili *-NR2C(O)-, gdje je R2 odabran od sljedećih: vodik, C1-4alkil, C1-4alkilamino-(C0-4)alkilen, C3-6cikloalkil-(C0-4)alkilen, C1-4heterocikloalkil-(C0-4)alkilen, dok je C4-6heterocikloalkil odabran iz skupine koju čine sljedeći: piperazinil, morfolinil, tiomorfolinil, tetrahidropiranil i oksetanil, i pri čemu je C3-6cikloalkil odabran od sljedećih: ciklopropil, ciklobutil, ciklopentil i cikloheksil;
svaki R1 je neovisno -C(O)NR7R8 ili –NH2, pri čemu su R7 i R8 svaki neovisno vodik ili C1-4alkil; i
R17 je odabran iz skupine koju čine cijano, halo.
10. Spoj prema zahtjevu 1, naznačen time, da je taj spoj ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, odabran iz skupine koja se sastoji od sljedećih:
N-(4-cijanofenil)-N-metil-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
4-fluoro-N-metil-N-((3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)metil)anilin;
N-(4-klorofenil)-N-metil-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-fluorofenil)-N-metil-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-metil-N-(5-metilpiridin-2-il)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
4-kloro-N-metil-N-((3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)metil)anilin;
N,5-dimetil-N-((3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)metil)piridin-2-amin;
5-((4-fluorofenoksi)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin;
N-(4-cijanofenil)-N-(2-metoksietil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-(2-(dimetilamino)etil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-((tetrahidro-2H-piran-4-il)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-(metilsulfonil)fenil)-N-((tetrahidro-2H-piran-4-il)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-metil-N-(5-metilpiridin-3-il)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
5-(((5-metilpiridin-2-il)oksi)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin;
5-(4-fluorofenetil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin;
N-(4-cijanofenil)-N-metil-3-(1-metil-1H-indazol-5-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(6-acetamidopiridin-3-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-fluorofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
5-(((4-fluorofenil)tio)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin;
5-(((4-fluorofenil)sulfinil)metil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin;
3-(4-(1H-pirazol-5-il)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-metil-3-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
(S)-3-(4-(2-aminopropanamido)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(5-karbamoilpiridin-2-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
4-cijano-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
4-fluoro-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
4-cijano-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzensulfonamid;
4-fluoro-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzensulfonamid;
3-(4-karbamoilfenil)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-metil-3-(4-(trifluorometil)fenil)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-metil-N-(5-(metilsulfonil)piridin-2-il)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-fluorobenzil)-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-amin;
N-(4-fluorobenzil)-N-metil-3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-amin;
N-metil-6-(trifluorometil)-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)nikotinamid;
N-metil-5-(trifluorometil)-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)pikolinamid;
4-cijano-N-((tetrahidro-2H-piran-4-il)metil)-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
N-(4-cijanofenil)-N-metil-3-(1H-pirolo[2,3-b]piridin-5-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(6-aminopiridin-3-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-aminofenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-(2-aminoacetamido)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
(R)-3-(4-(2-aminopropanamido)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
(S)-3-(4-(2-amino-3-metilbutanamido)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
(S)-3-(4-(2-amino-2-cikloheksilacetamido)fenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-fluorofenil)-1-metil-1-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)urea;
6-(1,1-difluoroetil)-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)nikotinamid;
6-ciklopropil-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)nikotinamid;
4-ciklopropil-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
5-fluoro-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)pikolinamid;
N-metil-4-(metilsulfonil)-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(1H-pirolo[2,3-b]piridin-5-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(6-aminopiridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
4-kloro-N-metil-N-(3-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
N-(3-(4-karbamoilfenil)pirazolo[1,5-a]piridin-5-il)-4-fluoro-N-metilbenzamid;
4-fluoro-N-metil-N-(3-(4-(5-(metilamino)-1,3,4-tiadiazol-2-il)fenil)pirazolo[1,5-a]piridin-5-il)benzamid;
N-metil-N-(5-(metilsulfonil)piridin-2-il)-3-(1H-pirolo[2,3-b]piridin-5-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(5-metilpiridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-3-(5-metoksipiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(5-karbamoilpiridin-2-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-metil-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-metil-N-(5-metilpiridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-fluorofenil)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
4-(5-(1-(metil(5-metilpiridin-2-il)amino)etil)pirazolo[1,5-a]piridin-3-il)benzamid;
4-(5-(1-(7-fluoro-3-okso-2H-benzo[b][1,4]oksazin-4(3H)-il)etil)pirazolo[1,5-a]piridin-3-il)benzamid;
N-(4-cijanofenil)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-(5-(1-(metil(5-metilpiridin-2-il)amino)etil)pirazolo[1,5-a]piridin-3-il)fenil)acetamid;
3-(4-acetamidofenil)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
4-(5-(7-fluoro-3,4-dihidro-2H-benzo[b][1,4]oksazin-4-karbonil)pirazolo[1,5-a]piridin-3-il)benzamid;
4-(5-(7-fluoro-3-metil-3,4-dihidro-2H-benzo[b][1,4]oksazin-4-karbonil)pirazolo[1,5-a]piridin-3-il)benzamid;
4-(5-(7-fluoro-3,4-dihidro-2H-benzo[b][1,4]oksazin-4-karbonil)pirazolo[1,5-a]piridin-3-il)-N-metilbenzamid;
4-(5-(7-fluoro-3-metil-3,4-dihidro-2H-benzo[b][1,4]oksazin-4-karbonil)pirazolo[1,5-a]piridin-3-il)-N-metilbenzamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-3-(4-(metilkarbamoil)fenil)-N-(oksetan-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(1-(1H-pirazol-1-il)propan-2-il)-3-(4-karbamoilfenil)-N-(5-cijanopiridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-fluoropiridin-3-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-amino-3,5-dimetilfenil)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-metilpiridin-3-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-cijanocikloheksil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(2-aminopirimidin-5-il)-N-(4-cijanofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-(trifluorometil)piridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-cijanopiridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-kloropiridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-(dimetilkarbamoil)piridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(6-amino-5-metoksipiridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-kloro-2-formilfenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-etil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-izopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
5-(5-(1-(4-cijanofenil)-2-metilhidrazinekarbonil)pirazolo[1,5-a]piridin-3-il)-N-metil pikolinamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
5-cijano-N-metil-N-(3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-il)pikolinamid;
N-etil-N-(5-fluoropiridin-2-il)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-etil-3-(4-(metilkarbamoil)fenil)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-metil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(5-amino-6-kloropiridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(4-klorofenil)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-klorofenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-3-(4-((2-hidroksietil)karbamoil)fenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-metil-3-(4-(metilkarbamoil)fenil)-N-(4-(trifluorometil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
3-(4-((2-aminoetil)karbamoil)fenil)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-cijanofenil)-N-(2-hidroksietil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
3-(6-kloro-5-(metilsulfonamido) piridin-3-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo [1,5-a]piridin-5-
karboksamid;
3-(2-aminopiridin-4-il)-N-(5-cijanopiridin-2-il)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(4-klorofenil)-N-metil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-(2-hidroksietil)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklobutil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(4-(piperidin-4-ilkarbamoil)fenil)pirazolo[1,5-a] piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-metil-3-(4-((2-(metilamino)etil)karbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-3-(4-((2-(dimetilamino)etil)karbamoil)fenil)-N-metilpirazolo[1,5-a]piridin-5-karboksamid;
N-(4-klorofenil)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-(ciklopropilmetil)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(tert-butil)-N-(5-cijanopiridin-2-il)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(5-cijanopiridin-2-il)-N-ciklopropilpirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(4-(izopropilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(4-(ciklopropilkarbamoil)fenil)pirazolo[1,5a]piridin-5-karboksamid;
N-(5-kloropiridin-2-il)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-ciklopropil-N-(5-fluoropiridin-2-il)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5 a] piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopentil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a] piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(4-(etilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-karbamoilpiridin-2-il)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-ciklopropil-N-(3,4-difluorofenil)-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(4-(oksetan-3-ilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-ciklopropil-3-(4-(metilkarbamoil)fenil)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklopropil-3-(5-(metilkarbamoil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-(4-cijanofenil)-N-ciklopropilpirazolo[1,5-a]piridin-5-karboksamid;
3-(4-karbamoilfenil)-N-ciklopropil-N-(3,4-difluorofenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-ciklopropil-3-(4-(metilkarbamoil)fenil)-N-(5-metilpiridin-2-il)pirazolo[1,5-a] piridin-5-karboksamid;
N-(4-cijanofenil)-N-ciklopropil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a] piridin-5-karboksamid;
3-(6-karbamoilpiridin-3-il)-N-(4-cijanofenil)-N-ciklopropilpirazolo[1,5-a]piridin-5-karboksamid;
3-(5-karbamoilpiridin-2-il)-N-(5-cijanopiridin-2-il)-N-ciklopropilpirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-etil-3-(4-[N-metilsulfamoil]fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-ciklopropil-3-(5-(metilkarbamoil)piridin-2-il)pirazolo[1,5-a] piridin-5-karboksamid;
3-(5-karbamoilpiridin-2-il)-N-(4-cijanofenil)-N-ciklopropilpirazolo[1,5-a]piridin-5-karboksamid;
N-(4-klorofenil)-N-ciklopropil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a] piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklobutil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-ciklobutil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(4-cijanofenil)-N-izopropil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
5-cijano-N-ciklopropil-N-(3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-il) pikolinamid;
N-(5-cijanopiridin-2-il)-N-izopropil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-etil-3-(6-[metilkarbamoil]piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-fluoropiridin-2-il)-N-izopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-izopropil-3-(6-(metilkarbamoil)piridin-3-il)-N-(5-(trifluorometil)piridin-2-il)pirazolo [1,5-a]piridin-5-
karboksamid;
N-izopropil-3-(4-(metilkarbamoil)fenil)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-izopropil-3-(5-(metilkarbamoil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-ciklobutil-3-(5-(metilkarbamoil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-fluoropiridin-2-il)-N-izopropil-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-etil-3-(6-(metilkarbamoil)piridin-3-il)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-(5-cijanopiridin-2-il)-N-etil-3-(4-(metilsulfonil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-etil-N-(5-fluoropiridin-2-il)-3-(6-(metilkarbamoil)piridin-3-il)pirazolo[1,5-a]piridin-5-karboksamid;
N-ciklobutil-3-(4-(metilkarbamoil)fenil)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
N,N-ciklobutil-3-(6-(metilkarbamoil)piridin-3-il)-N-(5-(trifluorometil)piridin-2-il)pirazolo[1,5-a]piridin-5-karboksamid;
4-(5-(N-(5-cijanopiridin-2-il)-N-metilsulfamoil)pirazolo[1,5-a]piridin-3-il)-N-metil benzamid;
4-(5-(N-(5-cijanopiridin-2-il)-N-ciklopropilsulfamoil)pirazolo[1,5-a]piridin-3-il)-N-metilbenzamid; i
4-(5-(N-(5-cijanopiridin-2-il)-N-ciklopropilsulfamoil)pirazolo[1,5-a]piridin-3-il)benzamid.
11. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
12. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
13. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
14. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
15. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
16. Spoj prema zahtjevu 10, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
17. Spoj, naznačen time, da je odabran od sljedećih:
4-(5-((5-cijanopiridin-2-il)(metil)karbamoil)pirazolo[1,5-a]piridin-3-il)benzojeva kiselina;
N-(5-(2-aminoetoksi)piridin-2-il)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
N-(6-metoksipiridin-3-il)-N-metil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid;
6-(N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamido) nikotinska kiselina;
N-(5-cijano-6-metoksipiridin-2-il)-N-ciklopropil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid; i
N-(5-cijano-6-(2-hidroksietoksi)piridin-2-il)-N-etil-3-(4-(metilkarbamoil)fenil)pirazolo[1,5-a]piridin-5-karboksamid,
ili njihova farmaceutski prihvatljiva sol.
18. Spoj prema zahtjevu 17, naznačen time, da je to:
[image]
ili njegova farmaceutski prihvatljiva sol.
19. Farmaceutski sastav, naznačen time, da obuhvaća najmanje jedan spoj prema bilo kojem od zahtjeva 1 do 18, ili njegovu farmaceutski prihvatljivu sol, te farmaceutski prihvatljiv nosač, razrjeđivač ili pomoćno sredstvo.
20. Spoj prema bilo kojem od zahtjeva 1 do 18, ili njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, naznačen time, da se upotrebljava samostalno ili u kombinaciji s nekim drugim sredstvom u liječenju, prevenciji, inhibiciji, poboljšavanju ili iskorjenjivanju patoloških i/ili simptomatičnih stanja bolesti koja je uzrokovana Plasmodium parazitom.
21. Spoj, njegova farmaceutski prihvatljiva sol, njegov tautomer ili stereoizomer, za uporabu u skladu sa zahtjevom 20, naznačen time, da navedena bolest je malarija.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261728018P | 2012-11-19 | 2012-11-19 | |
US201361847860P | 2013-07-18 | 2013-07-18 | |
PCT/US2013/070601 WO2014078802A1 (en) | 2012-11-19 | 2013-11-18 | Compounds and compositions for the treatment of parasitic diseases |
EP13795977.1A EP2925757B1 (en) | 2012-11-19 | 2013-11-18 | Compounds and compositions for the treatment of parasitic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20171998T1 true HRP20171998T1 (hr) | 2018-02-09 |
Family
ID=49667630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20171998TT HRP20171998T1 (hr) | 2012-11-19 | 2017-12-27 | Spojevi i sastavi za liječenje parazitnih bolesti |
Country Status (19)
Country | Link |
---|---|
US (3) | US9556169B2 (hr) |
EP (1) | EP2925757B1 (hr) |
JP (1) | JP6298472B2 (hr) |
CN (1) | CN105164124B (hr) |
AR (1) | AR093532A1 (hr) |
CY (1) | CY1119727T1 (hr) |
DK (1) | DK2925757T3 (hr) |
ES (1) | ES2655030T3 (hr) |
HR (1) | HRP20171998T1 (hr) |
HU (1) | HUE037600T2 (hr) |
LT (1) | LT2925757T (hr) |
ME (1) | ME03042B (hr) |
PL (1) | PL2925757T3 (hr) |
PT (1) | PT2925757T (hr) |
RS (1) | RS56720B1 (hr) |
SI (1) | SI2925757T1 (hr) |
TW (1) | TWI600654B (hr) |
UY (1) | UY35146A (hr) |
WO (1) | WO2014078802A1 (hr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA41338B1 (fr) * | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
RU2018130069A (ru) | 2016-01-21 | 2020-02-21 | Новартис Аг | Соединения и композиции для лечения криптоспоридиоза |
TWI679197B (zh) * | 2016-05-05 | 2019-12-11 | 瑞士商伊蘭科動物健康公司 | 雜芳基-1,2,4-三唑及雜芳基-三唑化合物 |
EP3484886B1 (en) * | 2016-07-14 | 2020-03-04 | Hoffmann-La Roche AG | 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases |
CN110023312A (zh) * | 2016-10-13 | 2019-07-16 | 由卫生与公众服务部部长代表的美利坚合众国 | 阻止疟疾寄生虫传播的化合物和方法 |
MA52337A (fr) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals Inc | Nouveaux analogues d'oxaborole et utilisations de ces derniers |
CN110650738B (zh) * | 2017-03-20 | 2023-05-09 | 博德研究所 | 用于治疗寄生虫病的化合物和方法 |
CN107037148B (zh) * | 2017-04-07 | 2019-11-19 | 上海药明康德新药开发有限公司 | 卤泛曲林的高效液相检测方法 |
JOP20190278A1 (ar) | 2017-05-31 | 2019-11-28 | Novartis Ag | مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية |
CN112996788A (zh) * | 2018-07-09 | 2021-06-18 | 勃林格殷格翰动物保健美国公司 | 驱蠕虫的杂环化合物 |
GB201811695D0 (en) * | 2018-07-17 | 2018-08-29 | Salvensis | Compounds for use in the treatment of fascioliasis |
JP2022526901A (ja) | 2019-03-19 | 2022-05-27 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物 |
WO2020247747A1 (en) * | 2019-06-07 | 2020-12-10 | Elanco Tiergesundheit Ag | Bicyclic derivatives for treating endoparasites |
PE20231205A1 (es) | 2020-05-29 | 2023-08-17 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos heterociclicos como anthelminticos |
WO2023275590A1 (en) | 2021-06-29 | 2023-01-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Detection of phosphoinositides in blood cells as a biomarker for alpha synuclein associated pathologies and a method of treatment of parkinson's disease and the related neurodegenerations |
WO2023057394A1 (en) | 2021-10-04 | 2023-04-13 | Forx Therapeutics Ag | N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer |
CA3181279A1 (en) * | 2022-03-24 | 2023-09-24 | Bloom Energy Corporation | Fuel cell stack assembly including heat sink inserts |
WO2024006974A2 (en) * | 2022-07-01 | 2024-01-04 | The Scripps Research Institute | Antimalarial compounds |
US20240124450A1 (en) | 2022-09-21 | 2024-04-18 | Pfizer Inc. | Novel SIK Inhibitors |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996034866A1 (en) | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
RO121272B1 (ro) | 1996-07-24 | 2007-02-28 | The Du Pont Merck Pharmaceutical Company | Azolotriazine şi pirimidine |
CA2295239A1 (en) | 1997-06-27 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Sulfonamide compounds and medicinal use thereof |
JP2001139575A (ja) | 1999-11-15 | 2001-05-22 | Fujisawa Pharmaceut Co Ltd | 新規ピラゾロピリジン誘導体 |
GB0002312D0 (en) | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
GB0002336D0 (en) | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
EP1261607B1 (en) * | 2000-03-01 | 2008-11-12 | Janssen Pharmaceutica N.V. | 2,4-disubstituted thiazolyl derivatives |
ES2222372T3 (es) | 2000-04-28 | 2005-02-01 | Glaxo Group Limited | Procedimiento de preparacion de derivados de pirazolopiridina. |
GB0018473D0 (en) | 2000-07-27 | 2000-09-13 | Merck Sharp & Dohme | Therapeutic agents |
PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
AUPQ969800A0 (en) | 2000-08-28 | 2000-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
EP1217000A1 (en) | 2000-12-23 | 2002-06-26 | Aventis Pharma Deutschland GmbH | Inhibitors of factor Xa and factor VIIa |
DE60227794D1 (de) | 2001-04-26 | 2008-09-04 | Eisai R&D Man Co Ltd | Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon |
AUPR916301A0 (en) | 2001-11-29 | 2001-12-20 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
CA2483306A1 (en) | 2002-04-23 | 2003-11-06 | Shionogi & Co., Ltd. | Pyrazolo[1,5-a]pyrimidine derivative and nad(p)h oxidase inhibitor containing the same |
US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
DE60315677T2 (de) | 2002-09-17 | 2008-06-05 | Eli Lilly And Co., Indianapolis | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs |
US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7488745B2 (en) * | 2004-07-16 | 2009-02-10 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
US7504424B2 (en) | 2004-07-16 | 2009-03-17 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
AU2005275213A1 (en) | 2004-07-16 | 2006-02-23 | Schering Corporation | Hydantoin derivatives for the treatment of inflammatory disorders |
BRPI0514094A (pt) | 2004-08-02 | 2008-05-27 | Osi Pharm Inc | composto, composição, e, método de tratamento de distúrbio hiperproliferativo |
AU2005295734A1 (en) | 2004-10-15 | 2006-04-27 | Biogen Idec Ma Inc. | Methods of treating vascular injuries |
CN101098870B (zh) | 2004-11-08 | 2010-11-03 | 万有制药株式会社 | 新型稠环咪唑衍生物 |
EP1828185B1 (en) * | 2004-12-21 | 2009-05-06 | SmithKline Beecham Corporation | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
WO2006070943A1 (ja) | 2004-12-28 | 2006-07-06 | Takeda Pharmaceutical Company Limited | 縮合イミダゾール化合物およびその用途 |
US7713975B1 (en) | 2005-01-12 | 2010-05-11 | Alcon, Inc. | 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
US20100216798A1 (en) | 2005-07-29 | 2010-08-26 | Astellas Pharma Inc | Fused heterocycles as lck inhibitors |
WO2007025090A2 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
TW200800213A (en) | 2005-09-02 | 2008-01-01 | Abbott Lab | Novel imidazo based heterocycles |
DE102005042742A1 (de) | 2005-09-02 | 2007-03-08 | Schering Ag | Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
ES2625378T3 (es) | 2005-09-27 | 2017-07-19 | Shionogi & Co., Ltd. | Derivado de sulfonamida que tiene actividad antagonista del receptor de PGD2 |
EP1963320A1 (en) | 2005-12-07 | 2008-09-03 | OSI Pharmaceuticals, Inc. | Pyrrolopyridine kinase inhibiting compounds |
US7795273B2 (en) | 2005-12-08 | 2010-09-14 | Novartis Ag | Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors |
WO2007086080A2 (en) | 2006-01-30 | 2007-08-02 | Glenmark Pharmaceuticals Limited | NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO2007096764A2 (en) | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
WO2007100775A2 (en) | 2006-02-27 | 2007-09-07 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
JP5352452B2 (ja) | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
DE102006029447A1 (de) | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel |
EP1873157A1 (en) | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
EP1900739A1 (en) | 2006-08-30 | 2008-03-19 | Cellzome Ag | Diazolodiazine derivatives as kinase inhibitors |
US20110021513A1 (en) | 2006-09-07 | 2011-01-27 | Biogen Idec Ma Inc. | Modulators of interleukin-1 receptor-associated kinase |
US20100093760A1 (en) | 2006-09-12 | 2010-04-15 | The General Hospital Corporation | Methods for identifying compounds that modulate cell signaling and methods employing such compounds |
ATE502943T1 (de) | 2006-09-29 | 2011-04-15 | Novartis Ag | Pyrazolopyrimidine als pi3k-lipidkinasehemmer |
CN101522682A (zh) | 2006-10-30 | 2009-09-02 | 诺瓦提斯公司 | 作为抗炎剂的杂环化合物 |
KR101546493B1 (ko) | 2006-11-06 | 2015-08-21 | 톨레로 파마수티컬스, 인크. | 이미다조[1,2-b]피리다진 및 피라졸로[1,5-a]피리미딘 유도체 및 단백질 키나제 억제제로서의 이의 용도 |
WO2008072682A1 (ja) | 2006-12-15 | 2008-06-19 | Daiichi Sankyo Company, Limited | イミダゾ[1,2-b]ピリダジン誘導体 |
AR064420A1 (es) | 2006-12-21 | 2009-04-01 | Alcon Mfg Ltd | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). |
JP5442448B2 (ja) | 2006-12-22 | 2014-03-12 | アステックス、セラピューティックス、リミテッド | Fgfrインヒビターとしての二環式ヘテロ環式化合物 |
KR20090112732A (ko) | 2007-01-26 | 2009-10-28 | 아이알엠 엘엘씨 | 플라스모듐 관련 질환의 치료를 위한 키나제 억제제로서의 퓨린 화합물 및 조성물 |
AU2008266856A1 (en) | 2007-06-18 | 2008-12-24 | University Of Louisville Research Foundation, Inc. | Family of PFKFB3 inhibitors with anti-neoplastic activities |
EP2176260A1 (en) | 2007-07-11 | 2010-04-21 | Auckland Uniservices Limited | Pyrazolo[1,5-a]pyridines and their use in cancer therapy |
AU2008275891B2 (en) | 2007-07-19 | 2013-10-10 | H.Lundbeck A/S | 5-membered heterocyclic amides and related compounds |
WO2009017954A1 (en) | 2007-08-01 | 2009-02-05 | Phenomix Corporation | Inhibitors of jak2 kinase |
KR20100128305A (ko) | 2008-02-28 | 2010-12-07 | 노파르티스 아게 | C-met 티로신 키나제 매개 질환의 치료를 위한 이미다조[1,2-b]피리다진 유도체 |
EP2265603B1 (en) * | 2008-03-13 | 2014-05-07 | The General Hospital Corporation | Inhibitors of the bmp signaling pathway |
US8507488B2 (en) | 2008-05-13 | 2013-08-13 | Irm Llc | Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
JP2009298710A (ja) | 2008-06-11 | 2009-12-24 | Daiichi Sankyo Co Ltd | イミダゾ[1,2−b]ピリダジン誘導体含有医薬組成物 |
JP5734183B2 (ja) | 2008-06-30 | 2015-06-17 | ヤンセン バイオテツク,インコーポレーテツド | 多能性幹細胞の分化 |
WO2010017046A1 (en) | 2008-08-05 | 2010-02-11 | Merck & Co., Inc. | Pyrazolo[1,5-a]pyridines as mark inhibitors |
WO2010017047A1 (en) | 2008-08-05 | 2010-02-11 | Merck & Co., Inc. | Therapeutic compounds |
US8198449B2 (en) | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
CN102223798A (zh) * | 2008-09-24 | 2011-10-19 | 巴斯夫欧洲公司 | 用于防治无脊椎动物害虫的吡唑化合物 |
WO2010059836A1 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
US20120010188A1 (en) | 2008-12-04 | 2012-01-12 | Promimagen Ltd. | Imidazopyridine Compounds |
WO2010074586A1 (en) | 2008-12-23 | 2010-07-01 | Pathway Therapeutics Limited | Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy |
CN102395585A (zh) * | 2009-01-30 | 2012-03-28 | 米伦纽姆医药公司 | 杂芳基化合物和其作为pi3k抑制剂的用途 |
EP2408753A4 (en) | 2009-03-20 | 2012-11-07 | Univ Brandeis | COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS |
WO2010108074A2 (en) | 2009-03-20 | 2010-09-23 | Amgen Inc. | Inhibitors of pi3 kinase |
US8927545B2 (en) | 2009-03-30 | 2015-01-06 | Duke University | Inhibiting Eph B-3 kinase |
EP2417138B1 (en) | 2009-04-09 | 2019-11-27 | Merck Sharp & Dohme Corp. | Pyrazolo[1, 5-a]pyrimidine derivatives as mtor inhibitors |
JO3156B1 (ar) | 2009-07-09 | 2017-09-20 | Novartis Ag | ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا |
RU2421455C2 (ru) | 2009-07-14 | 2011-06-20 | Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" | СПОСОБ ПОЛУЧЕНИЯ МЕТИЛ 7-АРИЛКАРБАМОИЛ-6-БЕНЗОИЛ-2-МЕТИЛ-3-ФЕНИЛПИРАЗОЛО[1,5-a]ПИРИМИДИН-5-КАРБОКСИЛАТОВ |
TW201107329A (en) | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
US8865726B2 (en) | 2009-09-03 | 2014-10-21 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors |
JP2013506624A (ja) | 2009-09-23 | 2013-02-28 | アミラ ファーマシューティカルズ,インク. | 5−リポキシゲナーゼのインドリジンインヒビター |
GB201002911D0 (en) | 2010-02-19 | 2010-04-07 | Medical Res Council | Compound |
JP2016500073A (ja) | 2012-11-19 | 2016-01-07 | ノバルティス アーゲー | 寄生虫病の処置のための化合物および組成物 |
-
2013
- 2013-11-18 PT PT137959771T patent/PT2925757T/pt unknown
- 2013-11-18 US US14/443,609 patent/US9556169B2/en active Active
- 2013-11-18 CN CN201380070822.0A patent/CN105164124B/zh not_active Expired - Fee Related
- 2013-11-18 TW TW102141950A patent/TWI600654B/zh not_active IP Right Cessation
- 2013-11-18 JP JP2015542882A patent/JP6298472B2/ja not_active Expired - Fee Related
- 2013-11-18 LT LTEP13795977.1T patent/LT2925757T/lt unknown
- 2013-11-18 DK DK13795977.1T patent/DK2925757T3/en active
- 2013-11-18 ME MEP-2017-266A patent/ME03042B/me unknown
- 2013-11-18 WO PCT/US2013/070601 patent/WO2014078802A1/en active Application Filing
- 2013-11-18 ES ES13795977.1T patent/ES2655030T3/es active Active
- 2013-11-18 SI SI201330889T patent/SI2925757T1/en unknown
- 2013-11-18 HU HUE13795977A patent/HUE037600T2/hu unknown
- 2013-11-18 PL PL13795977T patent/PL2925757T3/pl unknown
- 2013-11-18 RS RS20171296A patent/RS56720B1/sr unknown
- 2013-11-18 EP EP13795977.1A patent/EP2925757B1/en active Active
- 2013-11-19 AR ARP130104250A patent/AR093532A1/es unknown
- 2013-11-19 UY UY0001035146A patent/UY35146A/es unknown
-
2016
- 2016-07-26 US US15/220,149 patent/US9926314B2/en not_active Expired - Fee Related
-
2017
- 2017-12-27 HR HRP20171998TT patent/HRP20171998T1/hr unknown
-
2018
- 2018-01-03 CY CY20181100008T patent/CY1119727T1/el unknown
- 2018-02-06 US US15/889,578 patent/US20180230145A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN105164124B (zh) | 2017-03-15 |
CN105164124A (zh) | 2015-12-16 |
US20180230145A1 (en) | 2018-08-16 |
JP6298472B2 (ja) | 2018-03-20 |
ME03042B (me) | 2018-10-20 |
US9926314B2 (en) | 2018-03-27 |
PT2925757T (pt) | 2018-01-09 |
TWI600654B (zh) | 2017-10-01 |
HUE037600T2 (hu) | 2018-09-28 |
PL2925757T3 (pl) | 2018-06-29 |
AR093532A1 (es) | 2015-06-10 |
EP2925757B1 (en) | 2017-10-04 |
LT2925757T (lt) | 2017-12-27 |
SI2925757T1 (en) | 2018-01-31 |
US20160333012A1 (en) | 2016-11-17 |
UY35146A (es) | 2014-06-30 |
RS56720B1 (sr) | 2018-03-30 |
JP2016505529A (ja) | 2016-02-25 |
CY1119727T1 (el) | 2018-06-27 |
US9556169B2 (en) | 2017-01-31 |
TW201429967A (zh) | 2014-08-01 |
US20150344471A1 (en) | 2015-12-03 |
DK2925757T3 (en) | 2018-01-15 |
EP2925757A1 (en) | 2015-10-07 |
WO2014078802A1 (en) | 2014-05-22 |
ES2655030T3 (es) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171998T1 (hr) | Spojevi i sastavi za liječenje parazitnih bolesti | |
JP2016505529A5 (hr) | ||
KR101110530B1 (ko) | 증식성 질환의 치료에 유용한 키나제 억제제 | |
ES2620612T3 (es) | Derivados de sulfóxidos y sulfonas de piridinilo y pirimidinilo | |
HRP20160647T1 (hr) | Novi heterociklički derivati i njihova uporaba u liječenju neuroloških poremećaja | |
RU2650895C2 (ru) | Соединения замещенных пиразолонов и способы использования | |
JP2017531039A5 (hr) | ||
JP2009529047A5 (hr) | ||
WO2005079807A1 (en) | Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists | |
JP2004527560A5 (hr) | ||
KR20170026643A (ko) | Nadph 옥시다아제 억제제로서 피라졸로 피리딘 유도체 | |
MXPA01003855A (es) | Combinaciones de antagonistas del factor de liberacion de corticotropina y secretagogos de hormona del crecimiento. | |
HRP20181008T1 (hr) | Terapeutski aktivni pirazolo-pirimidin derivati | |
RU2018130069A (ru) | Соединения и композиции для лечения криптоспоридиоза | |
WO2011101805A1 (en) | Pyrazolo piperidine derivatives as nadph oxidase inhibitors | |
CA2976766A1 (en) | Formylated n-heterocyclic derivatives as fgfr4 inhibitors | |
HRP20161237T1 (hr) | Antimalarijski agensi | |
JP2016537384A5 (hr) | ||
EP3997088A4 (en) | DERIVATIVES OF 4-(IMIDAZO[L,2-A]PYRIDIN-3-YL)-N-(PYRIDINYL)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
HRP20211999T1 (hr) | Spojevi azaindolilpiridona i diazaindolilpiridona | |
JP2009502996A (ja) | IKK−β阻害剤との組合せ | |
RU2023126219A (ru) | Гетероциклические производные в качестве ингибиторов janus-киназы | |
HRP20210021T1 (hr) | Derivati pirazol[1,5-a]pirimidina kao inhibitori jak kinaze |